microdosing glp-1 for arthritis Why Microdosing? A Closer Look at Reported Benefits Stories like this are why

Read the full article in Journal of Substance Abuse Treatment: Learn more about the implementation research in addiction: #ImplementationScience #AddictionResearch #EvidenceBased #NIH #NIDA #PublicHealth #ResearchToPractice To view or add a comment, sign in Seventeen Years of Progress in NIDAs Investment in Implementation Research: How Far Weve Come

Here are some general guidelines to keep in mind: Take once daily, around the same time each day

Understanding exactly which compounds he uses provides valuable context for anyone researching these peptides

Lixisenatide, a structurally modified derivative of exendin-4, addresses some of these limitations by offering a longer half-life of approximately 3 h, thereby permitting once-daily dosing (Leon et al., 2017)